Trillium Therapeutics Provides Update on Its TTI-621 and TTI-622 Clinical Programs

    NEXT STORY
    Helix BioPharma Corp. Announces Regulatory Approval to Dose Patients in a Phase II Randomized Study of L-DOS47 With Vinorelbine and Cisplatin
    PREV STORY
    Loxo Oncology and Illumina to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Richard Hill, MD, PhD, is Elected to the American Health Council’s Board of Physicians

    NEW YORK, Jan. 31, 2018 (GLOBE NEWSWIRE) -- The American Health Council is honored ...

    author_avatar
    NASDAQ Market News

    Allarity Therapeutics Publishes Interim Report for the Period January – September 2020

    author_avatar
    NASDAQ Market News

    Diet Doc Helps Patients Choose the Best Diet by Including Nutritional Education that Clarifies the Difference Between Good and Bad Fat

    LOS ANGELES, Jan. 14, 2016 (GLOBE NEWSWIRE) -- Diet Doc is committed to helping ...

    author_avatar
    NASDAQ Market News